Abstract:Objective:To explore the role of Bcl2 and Caspase3 in modulating apoptosis of ERnegative breast cancer cells induced by tamoxifen. Methods:ERnegative breast cancer cell lines MDAMB231 were treated with 10.0μM tamoxifen for 12, 24, 36、48, 60 hours. The rate of cell apoptosis with or without caspase3 inhibitor AcDEVDCHO, and protein expression of Bcl2,Bax were determined by flow cytometry, and the activity of Caspase3 was examined with fluorophotometry. Results:The expression of Bcl2 was downregulated, the activity of Caspase3 and the rate of cell apoptosis were increased by TAM timedependently, and the rate of apoptosis reached its peak at 48 hours. The expression of Bcl2 was negatively correlated with activity of caspase3. Tamoxifen, however, did not affect Bax protein expression. AcDEVDCHO, a caspase3 inhibitor, blocked the activation of caspase3 and inhibited cell apoptosis induced by tamoxifen. Conclusions:TAM could induce apoptosis in ERnegative breast cancer cells via mitochondria pathway by downregulating Bcl2 expression, and the activation of Caspase3 might play an important role in the process of tamoxifeninduced apoptosis of ERnegative breast cancer cells.